Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Magnesium Citrate

Last content change checked dailysee data sync status

Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2026
Label revision date
March 4, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2026
Label revision date
March 4, 2026
Manufacturer
Walmart Inc.
Registration number
M007
NDC root
79903-410
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Equate Mag Citrate Cherry 2026 is a medication designed to provide relief from occasional constipation (irregularity). It works by helping to stimulate bowel movements, typically producing results within half an hour to six hours after taking it. This can be particularly helpful if you're experiencing temporary digestive discomfort and need a gentle solution to get things moving again.

Uses

If you're experiencing occasional constipation (irregularity), this medication can help provide relief. It typically works by encouraging a bowel movement within 30 minutes to 6 hours after taking it.

You can feel confident using this medication, as there are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with it.

Dosage and Administration

Before you take your medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass of liquid (8 ounces) along with it. You can take your medication either as a single dose each day or split it into smaller doses throughout the day.

For adults and children aged 12 and older, the recommended dose is between 6.5 to 10 fluid ounces, but you should not exceed 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should take 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day. For younger children aged 2 to under 6 years, the dose is 2 to 3 fluid ounces, and they should not exceed 3 fluid ounces in 24 hours. If your child is under 2 years old, it's important to consult a doctor before giving them this medication.

What to Avoid

If you experience rectal bleeding or do not have a bowel movement after using this medication, it is important to stop using it immediately and consult a doctor. These symptoms could indicate a serious health issue that requires medical attention.

Currently, there are no specific contraindications, risks of abuse or misuse, or concerns about dependence associated with this medication. However, always prioritize your health and safety by following the guidance provided.

Side Effects

You should be aware of some important side effects and warnings associated with this medication. If you have kidney disease or are on a magnesium-restricted diet, it's crucial to consult your doctor before use. Additionally, if you experience abdominal pain, nausea, or vomiting, or notice a sudden change in your bowel habits that lasts for more than two weeks, you should seek medical advice.

It's also important to stop using the medication and contact your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it, as these could indicate a serious condition. If you have been using a laxative for more than one week, please discuss this with your healthcare provider as well.

Warnings and Precautions

It's important to be aware of certain health conditions and symptoms before using this medication. If you have kidney disease or are on a magnesium-restricted diet, you should consult your doctor first. Additionally, if you experience abdominal pain, nausea, or vomiting, or notice a sudden change in your bowel habits that lasts for more than two weeks, it's crucial to seek medical advice. You should also avoid using a laxative for more than one week without consulting your healthcare provider.

In case of an overdose, please seek emergency medical help or contact a Poison Control Center immediately. If you experience rectal bleeding or do not have a bowel movement after using this medication, stop taking it and call your doctor right away, as these could indicate a serious health issue.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to minimize the risk of an overdose. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with your healthcare professional before using this medication. They can provide guidance on whether it is safe for you and your baby. Always prioritize open communication with your doctor regarding any medications you may be considering during this time.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with your healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

When it comes to giving this medication to children, it's important to follow specific guidelines based on their age. For children aged 12 years and older, the maximum amount you can give in a 24-hour period is 10 fluid ounces, with a typical range of 6.5 to 10 fluid ounces. For those between 6 and 12 years old, the recommended dosage is between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day.

If your child is between 2 and 6 years old, they should receive 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in 24 hours. For children under 2 years of age, it's best to consult a doctor before administering this medication. Always ensure you adhere to these guidelines to keep your child safe and healthy.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney disease, it's important to be aware of how it may affect your treatment. You may need to follow a magnesium-restricted diet, which means limiting foods high in magnesium to help manage your condition. This dietary adjustment is crucial for maintaining your overall health and ensuring your kidneys function as well as possible.

Always consult with your healthcare provider about any necessary dosage adjustments for medications, as your kidney function can influence how your body processes them. Regular monitoring of your kidney health is essential, so make sure to keep up with your appointments and follow your doctor's recommendations.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, and there are no special monitoring requirements or precautions outlined for patients like you.

However, it's always a good idea to discuss your liver health with your healthcare provider before starting any new medication. They can provide personalized advice and ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.

Storage and Handling

To ensure the best performance and safety of your product, store it at temperatures between 46°F and 86°F (8°C and 30°C). Keeping it within this temperature range helps maintain its effectiveness and integrity.

When handling the product, always do so with clean hands or gloves to avoid contamination. If you have any specific disposal instructions, please follow them carefully to ensure safe and responsible disposal.

Additional Information

No further information is available.

FAQ

What is Equate Mag Citrate Cherry used for?

Equate Mag Citrate Cherry is used for the relief of occasional constipation (irregularity).

How quickly does Equate Mag Citrate Cherry work?

It generally produces a bowel movement in 1/2 to 6 hours.

What should I do before using Equate Mag Citrate Cherry?

You should shake well before using and drink a full glass (8 ounces) of liquid with each dose.

What is the recommended dosage for adults and children over 12?

Adults and children 12 years of age and over should take 6.5 to 10 fl oz, with a maximum of 10 fl oz in 24 hours.

What is the dosage for children aged 6 to under 12?

Children 6 to under 12 years of age should take 3 to 7 fl oz, with a maximum of 7 fl oz in 24 hours.

What should children under 2 years of age do?

Children under 2 years of age should ask a doctor before use.

What should I do if I experience rectal bleeding?

You should stop using the product and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use.

Are there any warnings associated with Equate Mag Citrate Cherry?

Yes, you should be cautious if you have kidney disease, are on a magnesium-restricted diet, or experience abdominal pain, nausea, or vomiting.

What should I do in case of an overdose?

In case of overdose, get medical help or contact a Poison Control Center right away.

Is it safe to use Equate Mag Citrate Cherry during pregnancy or breastfeeding?

You should ask a health professional before use if you are pregnant or breastfeeding.

How should I store Equate Mag Citrate Cherry?

Store it at temperatures between 46° and 86°F (8° and 30°C).

Packaging Info

Below are the non-prescription pack sizes of Magnesium Citrate (equate magnesium citrate oral solution - cherry). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Magnesium Citrate.
Details

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose. The medication may be administered as a single daily dose or divided into multiple doses throughout the day.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period. For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period. For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period. For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition. In such cases, it is essential to discontinue use and consult a healthcare professional.

Warnings and Precautions

Patients with a history of kidney disease should exercise caution when using this medication, as it may exacerbate their condition. Additionally, individuals on a magnesium-restricted diet must be aware of the potential for increased magnesium levels, which could lead to serious complications.

Healthcare professionals should monitor patients for gastrointestinal symptoms such as abdominal pain, nausea, or vomiting. These symptoms may indicate an adverse reaction or intolerance to the medication. Furthermore, if a patient experiences a sudden change in bowel habits that persists for more than two weeks, it is imperative to evaluate the situation thoroughly, as this may signal an underlying issue requiring medical attention.

Patients who have been using a laxative for longer than one week should be advised to consult their healthcare provider before continuing treatment, as prolonged use may lead to dependency or other complications.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay to ensure appropriate management.

Patients must be instructed to discontinue use and contact their healthcare provider if they experience rectal bleeding or fail to have a bowel movement after using the medication. These symptoms could indicate a serious condition that necessitates prompt evaluation and intervention.

Side Effects

Patients should be aware of several important warnings associated with the use of this medication. Individuals with kidney disease or those on a magnesium-restricted diet should exercise caution. Additionally, patients experiencing abdominal pain, nausea, or vomiting should consider these symptoms as potential indicators of adverse reactions. A sudden change in bowel habits that persists for more than two weeks is also a significant concern, as is the use of a laxative for longer than one week.

Patients are advised to stop using the medication and consult a healthcare professional if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may signify a serious underlying condition.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate (equate magnesium citrate oral solution - cherry). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Magnesium Citrate.
Details

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage ranges from 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered in these populations. There is limited data available regarding the effects of this medication on fetal outcomes or during lactation, and therefore, caution is advised.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with kidney disease, it is essential to assess renal clearance to ensure appropriate therapeutic levels are maintained. Additionally, patients on a magnesium-restricted diet should be monitored closely, as renal impairment can affect magnesium levels and overall electrolyte balance. Regular evaluation of renal function is recommended to guide treatment decisions and minimize the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters have not been defined.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on the clinical presentation.

For further guidance, healthcare professionals should refer to established protocols and consult relevant toxicology resources.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or if they fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Patients should also be encouraged to consult with their healthcare provider or pharmacist prior to using this product if they are currently taking any other medications. It is essential to inform patients that this product should be taken at least 2 hours before or after the administration of other drugs, as laxatives may influence the efficacy of concurrent medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and safety. Proper container requirements must be adhered to, ensuring that the product is kept in an appropriate environment. Special handling needs should be observed to prevent any compromise to the product's integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Magnesium Citrate, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.